HOME >> BIOLOGY >> NEWS
Three Institutions Combine Efforts In First-Ever Demonstration Of Long-Term Function In Transplanted Human Liver Cells

A team of physicians and scientists from three medical centers has combined forces to show that an infusion of liver cells can function for more than a year to partially correct a patient's rare metabolic liver disease. The procedure, which is reported in this week's New England Journal of Medicine, suggests that cell transplantation may have broader application and be a safer and less invasive treatment than liver transplantation for some patients with disorders of the liver.

The liver cell infusion took place in April 1997 at the University of Nebraska Medical Center (UNMC) in Omaha and was performed on a 10-year-old girl suffering from Crigler-Najjar Syndrome Type I, a rare disease in which the liver does not make the enzyme that allows bilirubin, a blood cell byproduct, to be normally excreted by the body.

The team performing the procedure was headed by Ira Fox, M.D., a UNMC transplant surgeon who collaborated with J. Roy-Chowdhury, M.D. and N. Roy-Chowdury, Ph.D., liver disease experts at the Albert Einstein College of Medicine in Bronx, N.Y., and Stephen Strom, Ph.D., an expert in isolating human liver cells from the University of Pittsburgh.

"This is an important step forward," Dr. Fox said. "We now know that factors which have limited the long-term effectiveness of pancreatic islet cell transplants for the treatment of diabetes do not affect the long-term function of transplanted liver cells, at least for some liver disorders."

Because the body is unable to conjugate and normally excrete bilirubin, patients with Crigler-Najjar disease develop jaundice and must spend 12 hours a day or longer receiving phototherapy, which helps degrade the bilirubin in the skin, so it can be cleared from the body.

Other than a liver transplant, there is no cure for Crigler-Najjar disease. The oldest living patient with this disease is 31 years old and few pe
'"/>

Contact: Tom O'Connor
toconnor@unmc.edu
(402) 559-4690
University of Nebraska Medical Center
13-May-1998


Page: 1 2 3

Related biology news :

1. Three new South American fish identified
2. Three personal ads for physics
3. Three molecular-targeted compounds show promise against cancers
4. Three genes linked to psoriasis susceptibility identified on chromosome 17
5. Three Pacific Northwest National Laboratory inventions win R&D 100 Awards
6. Three Gorges Dam is an opportunity for ecoscience
7. Three tourist experiences named best worldwide for environmental, social responsibility
8. Three inferior prefrontal regions of the brain found receptive to somatosensory stimuli
9. Three dimensional structure of a protein transport machine
10. Three studies released this week shed new light on eating nuts for good health
11. Three nations agree to share ice core thatmay yield clues about nature of Lake Vostok

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/26/2019)... (PRWEB) , ... March 26, 2019 , ... ... proud to introduce the four recipients of the Society's 2019 Outstanding Achievement Award, ... four awards will be presented at the ASGCT 22nd Annual Meeting . ...
(Date:3/25/2019)... ... March 25, 2019 , ... Abcam, ... research organisation focused on advancing drug discovery, have announced a collaboration to develop ... clearing methods, which are essential to get a better view of complex structures ...
(Date:3/18/2019)... ... March 18, 2019 , ... Periodontal disease, where bacterial infection of ... 50% of the US population. Making this disease particularly challenging to treat is ... the cells are enmeshed in a sticky extracellular material that makes them more resistant ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... ... April 09, 2019 , ... Sonny Bar Lisa, or Sonny for ... approximately two months. After a series of diagnostics, an MRI was performed which ... Alison, researched the injury and found that VetStem Regenerative Cell Therapy may ...
(Date:4/8/2019)... , ... April 08, 2019 , ... US Capital ... a $15 million preferred equity investment in the privately held pharmaceutical company, S1 Biopharma ... drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ready to ...
(Date:4/4/2019)... BOSTON (PRWEB) , ... April 03, 2019 , ... ... leaders together through intimate off-the-record collaboration and dialogue, today announces its Boston CEO ... CEO offers insights into the industry’s challenges and opportunities with high-level panels and ...
(Date:3/27/2019)... ... March 27, 2019 , ... In honor of National Nutrition Month, Lajollacooks4u ... of healthy meals and good nutrition. This month, Chef Jodi Abel appeared on ... , The first segment addressed the nutritional value of USDA’s MyPlate, a ...
Breaking Biology Technology:
Cached News: